Dantrolene / Prazosin Capsule

This combination product integrates the peripheral skeletal muscle relaxant dantrolene with the alpha-1 adrenergic antagonist prazosin to provide a dual-mechanism approach for managing complex spasticity and associated autonomic dysfunction. The therapeutic synergy between these agents allows for enhanced modulation of neuromuscular tone and sympathetic outflow, optimizing clinical outcomes while potentially reducing the side-effect profile associated with high-dose monotherapy. Delivered in a convenient capsule format, this formulation ensures consistent bioavailability and improves patient adherence by streamlining the administration of two essential therapeutic pathways into a single oral dose.